Prescription drug · UNAPPROVED DRUG OTHER
Fluocinol Pak (fluocinonide) NDC 59088-755
Kit · PureTek Corporation
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 59088-755-00 | 59088075500 | 1 KIT in 1 KIT (59088-755-00) * 1 TUBE in 1 CARTON (45802-151-94) / 30 g in 1 TUBEMarketed from Jul 2, 2020 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Fluocinol Pak
- Generic name (nonproprietary)
- fluocinonide
- Dosage form
- Kit
- Labeler
- PureTek Corporation
- Product type
- Prescription drug
- Marketing category
- Unapproved drug (other)
- Marketing start
- Listing expires
- Identifiers
- Product ID 59088-755_f2051c68-cdea-58b2-e053-2995a90a6b48SPL ID f2051c68-cdea-58b2-e053-2995a90a6b48SPL set ID a9c88a41-3ff8-78f7-e053-2995a90adb8fRxCUI 485647
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N459088075500followed by a unit qualifier and the quantityPackage 59088-0755-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Fluocinonide Cream USP, 0.1% is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses in patients 12 years of age or older. Limitation of Use: Treatment beyond 2 consecutive weeks is not recommended and the total dosage should not exceed 60 g per week because of the potential for the drug to suppress the hypothalamic-pituitary-adrenal (HPA) axis. (1) Avoid use on the face, groin, or axillae. (1.2) Avoid use in perioral dermatitis or rosacea. 1.1 Indication Fluocinonide Cream USP, 0.1%, is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses in patients 12 ye…
Excerpt only. Read the full label for complete information.